4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-023720
PRESIDENT AND CEO sold 60,000 shares at an average $74.08 ($4,444,626)
- PRESIDENT AND CEO acquired 60,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Torley Helen PRESIDENT AND CEO | 2025-09-02 | Option exercise 10b5-1 | +20,000 | $8.11 | $162,200 | 753,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-02 | Sale 10b5-1 | −300 | $72.49 | $21,746 | 753,419 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-02 | Sale 10b5-1 | −16,288 | $73.70 | $1,200,393 | 737,131 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-02 | Sale 10b5-1 | −3,412 | $74.15 | $252,990 | 733,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-03 | Option exercise 10b5-1 | +20,000 | $8.11 | $162,200 | 753,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-03 | Sale 10b5-1 | −9,500 | $74.22 | $705,090 | 744,219 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-03 | Sale 10b5-1 | −10,500 | $74.63 | $783,636 | 733,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-04 | Option exercise 10b5-1 | +20,000 | $8.11 | $162,200 | 753,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-04 | Sale 10b5-1 | −9,900 | $73.54 | $728,006 | 743,819 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-04 | Sale 10b5-1 | −7,800 | $74.33 | $579,751 | 736,019 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-04 | Sale 10b5-1 | −2,300 | $75.22 | $173,015 | 733,719 | D |
| Derivatives | |||||||
| Torley Helen PRESIDENT AND CEO | 2025-09-02 | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162,200 | 176,569 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-03 | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162,200 | 156,569 | D |
| Torley Helen PRESIDENT AND CEO | 2025-09-04 | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162,200 | 136,569 | D |
| Open-market sales · 60,000 sh · avg $74.08 · $4,444,626 | |||||||
Loading xslF345X05/form4-09042025_090922.xml…